CD4 count at starting HAART | | |
>50 cells/mm3 | 4/17 (24%) | 0.7 |
<50 cells/mm3 | 4/11 (36%) | |
Viral load at starting HAART | | |
<5.5 log copies/ml | 3/14 (21%) | 0.7 |
>5.5 log copies/ml | 5/14 (36%) | |
Disseminated TB | | |
No | 2/15 (13%) | 0.09 |
Yes | 6/13 (46%) | |
CD4 cell response to HAART | | |
>100 cells/mm3 increase | 6/18 (33%) | 0.7 |
<100 cells/mm3 increase | 2/10 (20%) | |
Viral load (VL) response to HAART | | |
Achieved VL <400 copies/ml | 8/24 (33%) | 0.3 |
Did not achieve VL <400 copies/ml | 0/4 (0%) | |
Ethnicity | | |
Black African | 5/16 (31%) | 1.0 |
Other | 3/12 (25%) | |
Time from TB treatment to HAART | | |
<6 weeks | 7/13 (54%) | 0.03 |
6 weeks–6 months | 1/11 (9%) | |
>6 months | 0/4 (0%) | |